-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB BIO ANNOUNCES POSITIVE CONFIRMATORY CLINICAL RESULTS FROM THE PHASE 1 STUDY OF SAB-142 IN DEVELOPMENT FOR THE TREATMENT OF STAGE 3 T1D

Reuters·12/17/2025 13:00:04

Please log in to view news